Our work further illustrates that HDAC1 is a master regulator of pTh2 cells, suggesting that therapeutic approaches aimed at inhibiting HDACs in allergic asthma, like the use of SCFAs and synthetic HDAC inhibitors, should be revisited. The gene discussed is HDAC9; the disease is allergic asthma.